Published in Vaccine Weekly, June 14th, 2006
According to their report from the United States, "We describe a study testing fibrillar beta-amyloid1-42 (A-beta42 ) vaccination in dogs.
"Three young beagles (4.6 years) were immunized twice with A-beta42 and a Th1 adjuvant (TiterMax Gold)," explained Elizabeth Head at the University of California-Irvine and collaborators. "Animals generated primarily IgG2 and IgM antibody responses, which were specific for the A-beta11-30 region of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.